Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation

Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) suppresses protein translation. We previously reported eEF2K expression was upregulated in mesenteric arteries (MA) from spontaneously hypertensive rats (SHR). We have recently revealed A484954, an eEF2K inhibitor, acutely suppressed vasopressor a...

Full description

Bibliographic Details
Main Authors: Tomoko Kodama, Muneyoshi Okada, Hideyuki Yamawaki
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Journal of Pharmacological Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861320300712
_version_ 1819206342229884928
author Tomoko Kodama
Muneyoshi Okada
Hideyuki Yamawaki
author_facet Tomoko Kodama
Muneyoshi Okada
Hideyuki Yamawaki
author_sort Tomoko Kodama
collection DOAJ
description Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) suppresses protein translation. We previously reported eEF2K expression was upregulated in mesenteric arteries (MA) from spontaneously hypertensive rats (SHR). We have recently revealed A484954, an eEF2K inhibitor, acutely suppressed vasopressor agonists-induced increase of blood pressure (BP) in normal Wistar rats. In this study, we examined the acute effects of A484954 on BP in SHR and explored underlying mechanisms. BP was measured by a carotid cannulation method in SHR. Isometric contraction in MA from SHR was measured. Endothelial nitric oxide synthase (eNOS) dimerization was measured by low-temperature sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. A484954 lowered BP in 15-week-old SHR. A484954 induced relaxation in MA from both 4- and 7-9-week-old SHR. In MA from 4-week-old SHR, A484954-induced relaxation was inhibited almost completely by a NOS inhibitor, NG-nitro-l-arginine methyl ester (l-NAME) and significantly by a β blocker, propranolol. In MA from 7-9-week-old SHR, on the other hand, A484954-induced relaxation was inhibited partly either by l-NAME, indomethacin, a cyclooxygenase inhibitor, or l-NAME + indomethacin. A484954 promoted the dimerization of eNOS in human endothelial cells. In summary, we have revealed A484954 lowers BP in SHR perhaps through the vasorelaxation via the production of endothelium-derived relaxing factors.
first_indexed 2024-12-23T05:06:04Z
format Article
id doaj.art-f4392383a6804777b18b1bd8d9ba25f8
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-12-23T05:06:04Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-f4392383a6804777b18b1bd8d9ba25f82022-12-21T17:59:05ZengElsevierJournal of Pharmacological Sciences1347-86132020-11-011443165171Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxationTomoko Kodama0Muneyoshi Okada1Hideyuki Yamawaki2Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Higashi 23 Bancho 35-1, Towada, Aomori, 034-8628, JapanLaboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Higashi 23 Bancho 35-1, Towada, Aomori, 034-8628, JapanCorresponding author. Fax: +81 176 24 9456.; Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University, Higashi 23 Bancho 35-1, Towada, Aomori, 034-8628, JapanEukaryotic elongation factor 2 (eEF2) kinase (eEF2K) suppresses protein translation. We previously reported eEF2K expression was upregulated in mesenteric arteries (MA) from spontaneously hypertensive rats (SHR). We have recently revealed A484954, an eEF2K inhibitor, acutely suppressed vasopressor agonists-induced increase of blood pressure (BP) in normal Wistar rats. In this study, we examined the acute effects of A484954 on BP in SHR and explored underlying mechanisms. BP was measured by a carotid cannulation method in SHR. Isometric contraction in MA from SHR was measured. Endothelial nitric oxide synthase (eNOS) dimerization was measured by low-temperature sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. A484954 lowered BP in 15-week-old SHR. A484954 induced relaxation in MA from both 4- and 7-9-week-old SHR. In MA from 4-week-old SHR, A484954-induced relaxation was inhibited almost completely by a NOS inhibitor, NG-nitro-l-arginine methyl ester (l-NAME) and significantly by a β blocker, propranolol. In MA from 7-9-week-old SHR, on the other hand, A484954-induced relaxation was inhibited partly either by l-NAME, indomethacin, a cyclooxygenase inhibitor, or l-NAME + indomethacin. A484954 promoted the dimerization of eNOS in human endothelial cells. In summary, we have revealed A484954 lowers BP in SHR perhaps through the vasorelaxation via the production of endothelium-derived relaxing factors.http://www.sciencedirect.com/science/article/pii/S1347861320300712Eukaryotic elongation factor 2 kinaseHypertensionEndotheliumNitric oxideβ-adrenergic receptor
spellingShingle Tomoko Kodama
Muneyoshi Okada
Hideyuki Yamawaki
Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
Journal of Pharmacological Sciences
Eukaryotic elongation factor 2 kinase
Hypertension
Endothelium
Nitric oxide
β-adrenergic receptor
title Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
title_full Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
title_fullStr Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
title_full_unstemmed Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
title_short Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
title_sort eukaryotic elongation factor 2 kinase inhibitor a484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
topic Eukaryotic elongation factor 2 kinase
Hypertension
Endothelium
Nitric oxide
β-adrenergic receptor
url http://www.sciencedirect.com/science/article/pii/S1347861320300712
work_keys_str_mv AT tomokokodama eukaryoticelongationfactor2kinaseinhibitora484954loweredbloodpressureinspontaneouslyhypertensiveratsviainducingvasorelaxation
AT muneyoshiokada eukaryoticelongationfactor2kinaseinhibitora484954loweredbloodpressureinspontaneouslyhypertensiveratsviainducingvasorelaxation
AT hideyukiyamawaki eukaryoticelongationfactor2kinaseinhibitora484954loweredbloodpressureinspontaneouslyhypertensiveratsviainducingvasorelaxation